Search Results - "Kemos, P"

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN by Joosse, M. E., Aardoom, M. A., Kemos, P., Turner, D., Wilson, D. C., Koletzko, S., Martin‐de‐Carpi, J., Fagerberg, U. L., Spray, C., Tzivinikos, C., Sladek, M., Shaoul, R., Roma‐Giannikou, E., Bronsky, J., Serban, D. E., Ruemmele, F. M., Garnier‐Lengline, H., Veres, G., Hojsak, I., Kolho, K. L., Davies, I. H., Aloi, M., Lionetti, P., Hussey, S., Veereman, G., Braegger, C. P., Trindade, E., Wewer, A. V., Hauer, A. C., Vries, A. C. H., Sigall Boneh, R., Sarbagili Shabat, C., Levine, A., Ridder, L.

“…Summary Background Risk benefit strategies in managing inflammatory bowel diseases (IBD) are dependent upon understanding the risks of uncontrolled…”
Get full text

Periodontitis is strongly associated with NAFLD in the NHANES III cohort and in an independent prospective study, is more common in those with biopsy-proven advanced compared to mild liver disease by Alazawi, W, Tai, D.F, Kemos, P, Bernabe, E, Janicki, T, Gillam, D, Samsuddin, S, Syn, W.K, Turner, W

Get full text

Blood-test based assessment of liver fibrosis, but not transient elastography, is less accurate in NAFLD patients of South Asian compared to White ethnicity by De Silva, S, Li, W, Kemos, P, Brindley, J.H, Feakins, R, Chinaleong, J, Samsuddin, S, Foster, G.R, Syn, W.K, Alazawi, W

Get full text

P274 Renal failure in children with inflammatory bowel disease by Vuijk, S, Klomberg, R, Hellendoorn, A, Kemos, P, Aardoom, M, Ruemmele, F, Vrieling-Prince, F, Croft, N, de Ridder, L

“…Abstract Background Renal manifestations may occur in children with inflammatory bowel disease (IBD). The cause of renal manifestations is often unclear, but…”
Get full text

P678 Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry by Klomberg, R, Kemos, P, Chondrou, P, Croft, N, de Ridder, L

“…Abstract Background In addition to development of complicated disease behavior itself, children with Inflammatory Bowel Disease (IBD) are at risk of several…”
Get full text

G118(P) The risk of nephrotoxicity from 5-ASA in children with ulcerative colitis (UC) is not dose related by Vavilikolanu, R, Sanderson, I, Naik, S, Croft, NM, Kemos, P

“…Introduction5-aminosalicylate (5-ASA) is efficacious in UC and IBD-unclassified (U). Nephrotoxicity is a rare side-effect. In adults, 5-ASA-induced…”
Get full text

P114 Frequent work productivity and activity impairment in caregivers of children with inflammatory bowel disease: a project of the prospective PIBD-SETQuality inception cohort study by Klomberg, R, Kemos, P, Aardoom, M, Rizopoulos, D, Croft, N, de Ridder, L, Neyt, M

“…Abstract Background Paediatric inflammatory bowel disease (IBD) can disrupt daily lives of patients and their caregivers, who may be impaired in performing…”
Get full text

P146 Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease by Klomberg, R, van der Wal, H, Sarbagili, C, Kemos, P, Ruemelle, F, Croft, N, de Ridder, L, Levine, A

“…Abstract Background For paediatric patients with high risk of complicated Crohn’s disease (CD) [stricturing or penetrating disease], paediatric guidelines…”
Get full text

P243 The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international prospective study by Klomberg, R, Kaper, D, Barendregt, D, Vuijk, S, Schreurs, M, Charrout, M, Ruemmele, F, Kemos, P, Croft, N, Samsom, J, de Ridder, L

“…Abstract Background Pediatric-onset inflammatory bowel disease (PIBD) is a chronic disease with a heterogeneous spectrum. A better understanding of predicting…”
Get full text

P596 An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD by Aardoom, M A, Kemos, P, Ruemmele, F, Croft, N, de Ridder, L

“…Abstract Background Paediatric-onset IBD (PIBD) patients often present with more serious disease than adults and are exposed to intensive treatment, which may…”
Get full text

P116 The occurrence of venous thromboembolisms in paediatric-onset IBD by Aardoom, M, Kemos, P, Ruemmele, F M, van Ommen, C H, Croft, N M, de Ridder, L

“…Abstract Background Venous thromboembolisms (VTEs) are one of the severe adverse events that may occur in patients with paediatric-onset inflammatory bowel…”
Get full text

SAT-321 - Periodontitis is strongly associated with NAFLD in the NHANES III cohort and in an independent prospective study, is more common in those with biopsy-proven advanced compared to mild liver disease by Alazawi, W., Tai, D.F., Kemos, P., Bernabe, E., Janicki, T., Gillam, D., Samsuddin, S., Syn, W.K., Turner, W.

Get full text

P045 TIGIT expression differentiates regulatory from inflammatory Th1 gut-homing effector CD4+ T cells in inflammatory bowel disease patients by Heredia, M, Costes, L M M, Tindemans, I, Aardoom, M A, Klomberg, R C W, Kemos, P, Joosse, M E, van Haaften, D H, Tuk, B, Ruemmele, F, Croft, N M, Escher, J C, de Ridder, L, Samsom, J N

“…Abstract Background Crohn’s disease (CD) and ulcerative colitis (UC) are characterized by intestinal infiltration of pathogenic effector CD4+ T cells. The…”
Get full text

P021 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course by Heredia, M, Charrout, M, Klomberg, R, Aardoom, M, Jongsma, M, Kemos, P, van Haaften, D, Tuk, B, van Berkel, L, Bley Folly, B, Mahfouz, A, Reinders, M, Ruemmele, F, Croft, N, Escher, J, de Ridder, L, Samsom, J

“…Abstract Background Chronicity of inflammatory bowel disease (IBD) is driven by reactivation of inflammatory memory CD4+ T helper (Th) cells which activate an…”
Get full text

P012 Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn’s disease by Heredia, M, Costes, L, Tindemans, I, Aardoom, M, Klomberg, R, Kemos, P, Joosse, M, van Haaften, D, Tuk, B, Ruemmele, F, Croft, N, Escher, J, de Ridder, L, Samsom, J

“…Abstract Background Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a T cell driven intestinal inflammation…”
Get full text

P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet by Aardoom, M, Kemos, P, Ruemmele, F, Croft, N, de Ridder, L

“…Abstract Background Paediatric-onset inflammatory bowel disease (PIBD) reflects a more severe disease compared with adult forms, which leads to more intensive…”
Get full text

P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications by Kemos, P, Aardoom, M, Ruemmele, F, de Ridder, L, Croft, N

“…Abstract Background The incidence and prevalence of paediatric-onset inflammatory bowel disease (PIBD) and related complications is currently unknown or…”
Get full text

P165 A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort by Aardoom, M A, Kemos, P, Ruemmele, F, Tindemans, I, Samsom, J N, Croft, N, de Ridder, L

“…Abstract Background The consequences of paediatric IBD (PIBD), such as growth failure, bowel resection at young age and a lifelong risk of treatment-related…”
Get full text

SAT-320 - Blood-test based assessment of liver fibrosis, but not transient elastography, is less accurate in NAFLD patients of South Asian compared to White ethnicity by De Silva, S., Li, W., Kemos, P., Brindley, J.H., Feakins, R., Chinaleong, J., Samsuddin, S., Foster, G.R., Syn, W.K., Alazawi, W.

Get full text

P061 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course by Heredia, M, Charrout, M, Klomberg, R C W, Aardoom, M A, Jongsma, M M E, Kemos, P, van Haaften, D H, Tuk, B, van Berkel, L A, Bley Folly, B, Mahfouz, A, Reinders, M J T, Ruemmele, F, Croft, N, Escher, J C, de Ridder, L, Samsom, J N

“…Abstract Background Chronicity of inflammatory bowel disease (IBD) is driven by reactivation of inflammatory memory CD4+ T helper (Th) cells which activate an…”
Get full text